| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $55.8M | +7.8% |
| SG&A Expense | $20.4M | +19.6% |
| Operating Income | -$76.2M | -10.7% |
| Income Tax | $2K | +0.0% |
| Net Income | -$71.3M | -10.6% |
| EPS (Basic) | -$4.89 | +20.9% |
| EPS (Diluted) | -$4.89 | +20.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.6M | -17.6% |
| Current Assets | $75.8M | -14.8% |
| Total Assets | $79.9M | -15.8% |
| Current Liabilities | $15.2M | +23.1% |
| Total Liabilities | $18.2M | +10.8% |
| Stockholders' Equity | $61.7M | -21.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.6M | -20.2% |
| Investing Cash Flow | -$532K | -99.3% |
| Financing Cash Flow | $47.9M | -52.6% |